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Europium(III) Macrocyclic Chelates Appended with
Tyrosine-based Chromophores and Di-(2-picolyl)amine-
based Receptors: Turn-On Luminescent Chemosensors
Selective to Zinc(II) Ions
Gaoji Wang,[a] Carlos Platas-Iglesias,[b] and Goran Angelovski*[a]
Zinc ions play an important role in many biological processes in
the human body. To selectively detect Zn2+, two EuDO3A-based
complexes (DO3A=1,4,7,10-tetraazacyclododecane-1,4,7-tricar-
boxylic acid) appended with tyrosine as a chromophore and di-
(2-picolyl)amine (DPA) as the Zn2+ recognition moiety were
developed as suitable luminescent sensors. Their luminescence
intensity is affected by the photoinduced electron transfer
mechanism. Upon addition of Zn2+, both probes display an up
to sevenfold enhancement in Eu3+ emission. Competition
experiments demonstrated their specificity toward Zn2+ over
other metal ions, while also revealing the nonspecificity of the
derivatives lacking the DPA-moiety, thus confirming the
essential role of the DPA for the recognition of Zn2+. The
induced emission changes of Eu3+ allow for precise quantitative
analysis of Zn2+, establishing these lanthanide-based complexes
as viable chemosensors for biological applications.
Introduction
Zinc ions are the second most abundant transition metal ions in
the human body. They play a fundamental role in living systems
as they are involved in many essential biological processes,
including enzyme activity, signaling and gene transcription.[1] In
vivo, Zn2+ is present in the free and protein-bound form. The
abundance of Zn2+ is particularly important in the brain, breast,
prostate and pancreas.[2] While it is not redox active under
physiological conditions, Zn2+ deficiency is known to cause
increased oxidative stress contributing to the development of
different pathologies, such as cancer.[3] Therefore, its concen-
tration in healthy organs is highly regulated by the cells
through transporters and metallochaperones.[1c] Thus, imaging
Zn2+ by non-invasive techniques is of paramount importance to
understand its biological role and improve early-stage disease
detection.[1c]
Due to low cost and high instrument sensitivity, a large
number of optical probes and related toolboxes have been
developed for the detection of Zn2+ in the last few decades.[1d,4]
One of the commonly used chelators for sensing of Zn2+ is di-
(2-picolyl)amine (DPA),[5] which is known to form stable
complexes with Zn2+, providing the molecular recognition
complexes known as Zn-DPA.[6] Furthermore, combining the Zn-
DPA moiety with a luminescent center can result in Zn2+
-responsive optical imaging probes. In 2009, the Zn2+ sensor
Zinpyr-1 was synthesized and studied by Lippard and co-
workers.[7] Zinpyr-1, bearing the DPA moiety, can respond to
Zn2+ coordination through fluorescence quenching by photo-
induced electron transfer (PET)[8] occurring in the absence of
Zn2+. The presence of Zn2+ results in an enhancement in the
fluorescence emission intensity. The three nitrogen atoms of
DPA strongly coordinate Zn2+, with a dissociation constant (Kd)
in water media of around 10  10 M, giving rise to the ‘turn-on’
fluorescence response of Zinpyr-1.[7] However, this probe also
presents some disadvantages such as a small Stokes shift, low
water solubility, short lifetime and broad spectra of the
emission, limiting its application as an organic fluorescein
compound.[1a,6d]
Due to larger Stokes shifts (>200 nm), a longer emission
lifetime in the order of milliseconds and a higher water
solubility compared to the typical organic fluorescence com-
pounds, the complexes of lanthanide trivalent ions (Ln3+) such
as Eu3+ or Tb3+ have been employed as Zn2+-selective
sensors.[4b,9] In 2004, Nagano and coworkers developed a Eu3+
-based chemosensor appending a DPA arm for Zn2+
recognition.[1a] The quinolyl moiety was applied as a chromo-
phore to achieve a longer excitation wavelength (~320 nm).
Upon addition of Zn2+, the luminescence can be strongly
enhanced. To efficiently coordinate the Ln3+ ions, DO3A
(1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid) is widely
and successfully used as a backbone for the development of
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ligands. Given the high stability of DO3A-based Ln3+ com-
plexes, their properties such as luminescence and magnetic
behavior have been extensively studied.[9a,b,10] However, the
luminescence intensities of such LnDO3A complexes are very
weak due to their inefficient direct excitation (the f-f transitions
of the ions are Laporte-forbidden). Hence, the performance of
Ln3+-based luminescent probes may often be enhanced by
excitation of the Ln3+ via a sensitizing chromophore. This
moiety is included in the structure of the ligand giving the so-
called chromophore-luminophore complex.[10a,11] By combining
Ln3+ complexes and antenna moieties, the Laporte-forbidden
transitions can be circumvented. The natural amino acid
tyrosine (Tyr), bearing a phenol group can serve as a good
antenna.[9a,12] Once it is excited by UV light, radiationless energy
is transferred from tyrosine to the Ln3+ center, resulting in the
characteristic luminescence of this metal ion.
To build upon the previous studies and prepare a potent
Zn2+ luminescence lanthanide-based sensor, we designed,
synthesized and investigated two Eu3+ probes, EuL1 and EuL2,
functionalized with Tyr as a chromophore and DPA as the Zn2+
recognition moiety (Figure 1). The Tyr unit was incorporated
into the ligand designed to serve as an antenna, transferring
energy efficiently to Eu3+, and also as a molecular linker that
connects the Eu3+ and Zn2+ chelating units. These two probes
were anticipated to show an enhancement of luminescence
upon Zn2+ addition with a long wavelength Eu3+-centered
emission (617 nm). Hence the large apparent Stokes shift
between the excitation and emission wavelengths of the
antenna and the lanthanide metal ion, respectively (~300 nm),
combined with the high water-solubility typically expected for
such complexes, could potentially be utilized for practical
applications. Furthermore, two additional complexes EuL3 and
EuL4 lacking the DPA-moiety were synthesized and utilized for
comparative studies (Figure 1), expecting to highlight the effect
of the Zn2+-sensitive chelator on the final properties of the
complexes.
Results and Discussion
Design and synthesis of EuL1  4
The probes EuL1  4 were synthesized in a stepwise manner,
starting from the protected amino acid Boc-Tyr-OMe
(Scheme 1). Firstly, DPA was coupled to Boc-Tyr-OMe to give 1
following a previously reported literature procedure.[13] Subse-
quently, this molecule was coupled to the DO3A moiety by
reacting 1 with tBuDO3A in the presence of paraformaldehyde
at 110 °C to afford macrocycle 2.[14] The ligand L1 was obtained
by treating 2 with TFA in CH2Cl2, followed by HPLC purification.
Subsequently, basic hydrolysis of the methyl ester of L1 was
achieved with LiOH giving L2 (Scheme 1a). In parallel, the
ligands L3,4 were prepared directly by combining the amino
acid Boc-Tyr-OMe and the tBuDO3A to give the macrocycle 3Figure 1. Chemical structures of EuL1  4 discussed in this work.
Scheme 1. The synthetic routes to ligands a) L1,2 and b) L3,4. Reagents and conditions: i) MeOH, di-(2-picolyl)amine, (CH2O)2, 65 °C, 5 h; ii) DBU, (CH2O)2, toluene,
110 °C, 6 h for 2 and 65 °C, 3 h for 3; iii) TFA, CH2Cl2, 18 h; iv) LiOH, MeOH, 18 h.
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(Scheme 1b). Acid hydrolysis with TFA resulted in the ligand L3,
which was further subjected to basic hydrolysis with LiOH to
provide the ligand L4. Finally, all the complexes EuL1  4 were
prepared by treating the ligands with EuCl3 · 6H2O in water,
while maintaining the pH at ~7.
Luminescence properties of EuL1  4
Competition with biologically relevant cations
The EuL1  4 complexes present weak luminescence upon
excitation through the ligand bands at 322 nm (HEPES buffer,
pH 7.4). Due to such weak emission, no luminescence lifetime
values could be determined to evaluate the hydration number
(q) of each complex. Instead, estimation of the hydration state
of the studied complexes was based on the results obtained
from the relaxometric studies of the Gd3+ analogues (see
below).
The addition of Zn2+ has quite different effects on the
luminescence emission intensity for these complexes. Specifi-
cally, both EuL1 and EuL2 exhibit an increase in emission
intensity upon the addition of one equivalent of Zn2+, while
another equiv. of Zn2+ causes a further but smaller increase in
emission for EuL1 only. Meanwhile, both EuL3,4 remain insensi-
tive to the addition of Zn2+, confirming that the presence of the
DPA moiety is essential to affect the luminescence emission
(Figure 2a).
The selectivity of EuL1,2 was further tested by addition of
metal ions commonly found in biological systems. Chloride salts
of K+, Na+, Ca2+, Mg2+, Fe2+ and Fe3+ (3 equiv.) do not provoke
significant changes in the intensity of the Eu3+ 5D0!
7FJ
transitions (J=0 to 4),[15] while Cu2+ almost completely
quenches the Eu3+-based luminescence. Subsequent addition
of Zn2+ (3 equiv.) results in a dramatic enhancement of the
emission intensity in the presence of K+, Na+, Ca2+, Mg2+, Fe2+
and Fe3+, indicating the selective response of EuL1,2 to Zn2+ in
the presence of these competing metal ions (Figures 2b and S1
in the Supporting Information). Only Cu2+ was found to
compete efficiently with Zn2+ among the metal ions examined
in this study. This is however expected considering the higher
affinity of DPA for Cu2+ compared with Zn2+,[16] and the known
ability of Cu2+ to quench the emission of organic chromophores
due to its partially occupied 3d shell.[17] However, the
luminescence quenching effect of Cu2+ is not likely to be a
significant problem for practical applications because free
copper ions in living cells are present in very low quantities.[18]
As expected, EuL3,4 exhibit weak and random luminescence
changes toward all of these studied ions. The high selectivity
toward Zn2+ suggested that probes EuL1  2 can be useful for
potential biological applications.
Titrations with Zn2+ . Since EuL1 and EuL2 exhibited differ-
ent responses to the addition of Zn2+, we conducted more
detailed studies with these two systems. Increasing amounts of
Zn2+ were added to an aqueous solution of EuL1 (50 μM) and
the steady-state emission spectra were recorded from 560 to
720 nm using the same excitation wavelength (322 nm). By
following the most intense 5D0!
7F2 transition, the titration
profile presents two inflection points close to 1 :1 and ~1 :2
(Eu3+ : Zn2+) stoichiometry ratios, reaching a plateau with further
Zn2+ addition of up to 4 equiv. (Figure 3). The emission intensity
of EuL1 increased significantly (about 7-fold at 617 nm) upon
the addition of two equiv. of Zn2+, with a large apparent Stokes
shift (295 nm). These results indicate the presence of two
different Zn2+ binding sites: the initial increase of luminescence
intensity should be ascribed to the complexation between DPA
and Zn2+, while the second should be related to the weak
interaction between the amino acid methyl ester of tyrosine
and Zn2+ (Figure 3 inset). The emission spectra of EuL1 were
analyzed to a model including the formation of both 1 :1 and
1 :2 (Eu3+ : Zn2+) species, affording association constants of
logK11=7.15�0.03 and logK12=4.59�0.02 (Figure S2 in the
Supporting Information). Obviously, the binding of the first
equivalent of Zn2+ is very strong, while the second binding
process is weaker. The first association constant is virtually
identical to that determined for [Zn(DPA)]2+ at pH 7.0 (logK11=
7.15).[19]
Figure 2. a) Luminescence changes of EuL1  4 (50 μM) upon addition of Zn2+.
All data were recorded in HEPES buffer (50 mM, pH 7.4) with λex=322 nm
and λem=617 nm; intensity was estimated by the peak height at
λem=617 nm. b) Luminescence variations of EuL
1 (50 μM) to Zn2+ in the
presence of different metal ions. Blue bars indicate luminescence intensity of
EuL1 in the presence of various metal ions (3 equiv.). Green bars indicate
luminescence intensity of EuL1 after the subsequent addition of Zn2+
(3 equiv.).
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Further insights into the behavior of these systems were
obtained by repeating the titration experiments with EuL2,
which bears a carboxylic acid on the Tyr moiety instead of a
methyl ester group as in EuL1 (Figure S3 in the Supporting
Information). The luminescence changes were investigated
upon addition of Zn2+ within the same concentration range (0–
4 equiv.). Here, the emission intensity increases 5-fold and only
up to the addition of one equiv. of Zn2+. The analysis of the
data according to a 1 :1 binding model resulted in an
association constant with a value of logK11=7.1�0.1, indicating
strong binding of Zn2+ to the DPA-tyrosine moiety (Figure S2 in
the Supporting Information). We hypothesize that the amino
acid of EuL2 exists as a zwitterion at physiological pH,[20] which
consequently induces the observed luminescence increase with
only one equiv. of Zn2+. The situation is slightly different in
EuL1, where the DPA-tyrosine moiety dominates the turn-on
response of luminescence; however, the positively charged Tyr
moiety in the form of a methyl ester interacts with the second
equiv. of Zn2+, thus further promoting the luminescence
emission.
Luminescence pH titrations
The pH dependence of the emission intensity of EuL1 and
EuL1Zn was investigated to shed light into the mechanism
responsible for the turn-on response to Zn2+ (Figure 4). For
EuL1, in the absence of Zn2+, the luminescence is gradually
quenched by increasing pH. This is a result of photoinduced
electron transfer (PET) caused by the lone pair of electrons from
the DPA moiety.[21] Protonation of the amine nitrogen atom of
the DPA moiety decreases the energy of the nitrogen lone pair,
thus preventing the PET process. The fitting of the pH titration
profile provides a pKa of 8.3�0.1, indicating that the DPA group
is largely protonated under physiological conditions.
For EuL1Zn (EuL1 with 2 equiv. Zn2+), the luminescence is
gradually enhanced with increasing pH, providing a pKa of 7.6�
0.1. The relatively high equilibrium constant determined for the
association of EuL1 with Zn2+ (see above) indicates that nearly
all Zn2+ present in solution is already bound to the DPA moiety
at pH 7.4. Subsequently, the pH dependent changes in
luminescence emission observed for EuL1Zn should be ascribed
to a protonation process that does not involve the DPA moiety,
but is likely related to the protonation/deprotonation of the
phenol unit. This pKa is considerably lower than that deter-
mined in the absence of Zn2+ (pKa=9.4�0.5, see below), which
opens the question of whether the phenol group remains
coordinated to the lanthanide ion upon protonation. Indeed,
Sherry et al. showed that a GdDO3A derivative containing a
methylene nitrophenol pendant arm provided a relaxivity
response to pH, as protonation of the phenol group provokes
its dissociation from the lanthanide center, resulting in an
increase of the number of coordinated water molecules.[22]
Similarly to EuL1, the EuL2 and EuL2Zn complexes show
similar pH titration profiles (Figure S4 in the Supporting
Information). Here, the pKa values are almost identical to those
of the EuL1/EuL1Zn pair, resulting in values of 8.2�0.1 and
7.5�0.1 for EuL2 and EuL2Zn, respectively. This provides
additional evidence that the pKa observed for the EuL
1Zn
complex can be associated to the protonation of the phenol
group from the Tyr moiety. Indeed, the similar pKa values of the
EuL1,2/EuL1,2Zn systems suggest that both groups experiencing
protonation (amine and phenol groups of the DPA and phenol
moieties, respectively) are not affected significantly by the
different functional groups of the amino acid part of Tyr, i. e. the
ester and free acid in EuL1 and EuL2, respectively. The carboxyl
group, being either protected as an ester or not, is apparently
sufficiently isolated from the remaining part of the DPA-Tyr
moiety to influence the protonation processes of groups
substantially involved in the luminescence emission.
UV-Vis studies of EuL1,2. Further studies with the inves-
tigated complexes were performed by means of UV-Vis
spectrophotometry, in order to reveal new insights that could
not be obtained with the luminescence emission experiments.
Firstly, UV-Vis absorption spectra of solutions of EuL1,2
(50 μM) at pH 7.4 were recorded in the presence of various
concentrations of Zn2+ (0–3 equiv). The spectra are dominated
Figure 3. Luminescence emission spectral variations of EuL1 (50 μM,
λex=322 nm, λem=617 nm) upon titration with Zn
2+ (50 mM HEPES, pH 7.4,
25 °C). Inset: normalized emission intensities of EuL1 as a function of Zn2+
concentration.
Figure 4. Luminescence emission intensity variations with pH changes of
EuL1 (open symbols) and EuL1Zn (filled symbols) in water (50 μM complex,
100 mM KCl as the electrolyte, λex=322 nm; intensity was estimated by the
peak height at λem=617 nm). The dashed lines represent fitted values as
described in the Experimental section, while the green arrow shows the
luminescence emission change at pH 7.4.
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by an intense absorption around 250 nm attributable to the
pyridyl units of the DPA moiety,[23] and a second broad band
with a maximum around 305 nm characteristic of the phenol
group.[24] Addition of 1 equiv. of Zn2+ causes a slight blue shift
of the band of EuL1 with maximum at 305 nm to 295 nm
(Figure 5), whereas the same type of shift from 306 nm to
296 nm takes place for EuL2 (Figure S5 in the Supporting
Information). Further addition of Zn2+ did not induce noticeable
changes. This is consistent with the previously observed
luminescence effects: binding of Zn2+ to the amine group of
Tyr does not affect the UV spectrum of EuL1, while EuL2 already
exhibited insensitivity towards Zn2+ beyond 1 equiv. added (see
above). Furthermore, the band with a maximum at 250 nm and
248 nm for EuL1 and EuL2, respectively, experiences a dramatic
intensity decrease upon Zn2+ addition, which confirms the
binding of the metal ion to the DPA moiety of the ligand. No
UV-Vis absorbance changes were found for EuL3 or EuL4
(50 μM) at pH 7.4 in the presence and absence of Zn2+.
UV-Vis absorption of EuL1 (50 μM) was also studied at
different pH values to find out whether the phenol group of
tyrosine is involved in binding to Eu3+. The absorption spectra
were recorded from pH ~ 4.0 to ~11.0 (Figure 6). Increasing the
pH provokes a decrease of the band at 303 nm while a new
maximum at 335 nm develops. Conversely, the band at 250 nm
remains nearly unaffected by pH. The analysis of the absorb-
ance changes at 335 nm provides a pKa=9.4�0.5. These results
suggest that the phenol group is involved in protonation/
deprotonation processes, specifically being protonated at
physiological pH.
Finally, to confirm the binding relationship of Zn2+ with
EuL1,2, a method of continuous variation was applied on both
complexes and Job’s plots were obtained (Figure S6 in the
Supporting Information).[25] The experiments were performed
with the total concentration of [Zn2+]+ [EuL1,2]=50 μM and
their result confirmed that EuL1 possesses two Zn2+-binding
sites, as it presents a maximum close to xZn2+ =0.60.
[26] The
same experiment performed for EuL2 indicates a 1 :1 ratio of
binding to Zn2+, matching the obtained results from the
luminescence titration experiments (see above).
Longitudinal relaxivity of Gd3+ complexes
The coordination properties of the studied systems were also
assessed by preparing highly paramagnetic Gd3+ analogues of
EuL1,2 and testing their relaxometric response in the presence
of Zn2+. The synthesis of GdL1,2 was performed in the same
manner as for EuL1,2 by chelating Gd3+ in the form of the
chloride hydrate with the respective ligand L1,2. Subsequently,
the longitudinal relaxivity, r1, was determined for both com-
plexes in the absence or presence of different concentrations of
Zn2+ (Figure S7 in the Supporting Information). Initial r1 values
for both complexes are high (7.35 and 7.95 mM  1 s  1 for GdL1
and GdL2, respectively), which suggests the presence of
monohydrated complexes in both cases. Addition of Zn2+ to
GdL1 causes a rather small increase in relaxivity of ~10% (r1=
8.21 mM  1 s  1 upon addition of 5 equiv. of Zn2+). This small
relaxivity enhancement is not compatible with a change in the
hydration number of the complex, but rather to some effect on
the rotational dynamics of the complex in the presence of two
Zn2+ ions or a change in the water exchange. Additionally, the
relaxometric titrations of GdL2 with Zn2+ resulted in negligible
relaxivity changes, with the r1 value remaining in the range 7.9–
8.0 mM  1 s  1, confirming that the hydration number of the
complex remains unchanged when Zn2+ is added to the
solution. Moreover, r1 values for both complexes are very similar
to those recorded under identical conditions for monohydrated
GdDO3A-type derivatives with similar size.[27] This suggests that
the phenolate group remains coordinated to the metal ion
upon protonation, and that the electron withdrawing effect of
the nitro substituent at position 4 of the phenol group in the
complex reported by Woods et al. is responsible for its
dissociation when protonated.[22]
DFT calculations
DFT calculations were carried out to aid the rationalization of
the observed results. The optimized structure of the EuL1
complex supports octadentate binding of the ligand to the Eu3+
ion, with average Eu  N and Eu  Ocarboxylate distances of 2.67 and
2.38 Å, respectively. The Eu  Ophenol distance of 2.56 Å is
relatively long, and decreases to 2.34 Å upon deprotonation.
Figure 5. UV-Vis absorption titrations of EuL1 (50 μM) with Zn2+ (50 mM
HEPES buffer at pH 7.4). Inset: absorption intensity variations at 250 nm with
Zn2+ addition.
Figure 6. Changes in the UV-Vis absorbance of EuL1 (50 μM in water) upon
variations in pH. Inset: absorption intensity variations at 335 nm with pH
changes.
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Calculations were also performed on the EuL1ZnCl2 system, in
which two chloride anions were included to complete the
square-pyramidal coordination of Zn2+ observed for DPA
derivatives of this metal ion in the presence of Cl  .[28] The
experimental data were obtained using 100 mM KCl as back-
ground electrolyte, and thus Cl  coordination is expected.
The coordination of Zn2+ to the DPA moiety provokes little
changes in the Eu3+ coordination environment (Figure 7), but
significant changes in the frontier molecular orbitals. Indeed,
the HOMO of EuL1 is mainly located on the amine nitrogen
atom of the DPA moiety, with some contribution of the lone
pairs of the pyridyl nitrogen atoms. Conversely, the LUMO is
comprised of π orbitals of the pyridyl and phenol groups. The
HOMO of the EuL1ZnCl2 system is predicted to be centered on
one of the carboxylate groups of the DO3A unit, while the main
contributions to the LUMO are provided by π orbitals of the
pyridyl groups. Both the HOMO and the LUMO are significantly
stabilized upon Zn2+ coordination (Figure 7). These results are
in line with a PET mechanism being responsible for the turn-on
luminescence response of EuL1 to Zn2+.[9b] PET sensors are
responsive electron donor-acceptor probes in which the HOMO
of the donor (the lone pair of the amine N atoms in this case)
presents a higher energy than the acceptor in the absence of
the target analyte. As a result, excitation of the LUMO results in
an electron transfer from the HOMO of the donor to the HOMO
of the acceptor, quenching the emission of the probe.
Coordination of Zn2+ to the DPA moiety reduces the energy of
the HOMO of the donor, enhancing the overall luminescence.
Conclusion
We studied a series of EuDO3A-based complexes as potential
luminescence chemosensors for the detection of Zn2+. All
complexes were appended with tyrosine as a chromophore,
while only two that contained DPA as a recognition moiety for
Zn2+ exhibited properties suitable for the desired luminescent
sensors. In the absence of Zn2+, only weak luminescence of
each probe was observed due to quenching of luminescence
caused by the PET mechanism involving the deprotonated
amine group of DPA. Upon the addition of Zn2+, both DPA-
containing probes displayed large increases in Eu3+-centered
luminescent emission, which reached up to sevenfold
enhancement. The ion selectivity experiments demonstrated
the specificity of these probes toward Zn2+ over other bio-
logically relevant metal ions. The two complexes without a
DPA-moiety did not show any obvious luminescent
enhancement for any of the studied metal ions, emphasizing
the essential role of DPA for the recognition of Zn2+. Extensive
luminescence, UV-Vis and relaxometric studies that involved pH
and Zn2+ titrations or theoretical DFT calculations revealed the
major properties of the chemosensors in aqueous solution.
They also provided essential mechanistic insights of their
interaction with Zn2+ and the consequence of this interaction
on the subsequent luminescence emission. For future studies, it
would be desirable to design a complex in which both
protonation constants (of the amine of DPA and phenol on Tyr
units) are lowered, thus promoting greater change in the
luminescence intensity upon Zn2+ addition by: a) achieving
greater quenching by the DPA group/free electron pair in the
absence of Zn2+, and b) further enhancing the signal by
deprotonating the phenol group upon Zn2+ addition. Overall,
the results reported in this work allowed for precise quantitative
analysis of the interaction of Eu3+ luminescent complexes
together with Zn2+ as the target analyte. It also provided
important insights which can assist further in establishing Ln3+
-based complexes as useful chemosensors for potential bio-
logical applications that range from the development of differ-
ent bioassays to medical optical imaging.
Experimental Section
General
The reagents were purchased from Aldrich and were used without
further purification. Compound 1 was synthesised following a
previously published procedure.[13] Purification of synthesized
compounds was performed using silica gel 60 (0.03–0.2 mm) from
Carl Roth (Germany). The buffer solution (0.1 M HEPES, pH 7.4) was
prepared by dissolving solid HEPES in HPLC grade water. After the
solution became clear, aqueous NaOH (1 M) was added to adjust
the pH to the desired value. The buffer solution was used without
degassing. All UV-vis absorption and fluorescence spectra were
recorded on an Agilent Cary 60 UV-Vis Spectrophotometer and a
QuantaMasterTM 3 PH fluorescence spectrometer from Photon
Technology International, Inc. (USA), respectively. Low resolution
mass spectra were recorded on an ion trap SL 1100 system Agilent
with an electrospray ionization source. High resolution mass spectra
were recorded on a Bruker Daltonics APEX II (FT-ICR-MS) with an
electrospray ionization source. MALDI-TOF-MS analysis was per-
formed by The Scripps Center for Mass Spectrometry, La Jolla, CA.
1H and 13C NMR spectra were recorded on a Bruker Avance III
300 MHz spectrometer at 25 °C. Processing was performed using
TopSpin 2.1 (Bruker GmbH) and ACD/SpecManager 9.0 (Advanced
Chemistry Development, Inc.). The concentration of Gd3+ and Eu3+
Figure 7. Views of the frontier molecular orbitals of EuL1 and EuL1ZnCl2
obtained with DFT calculations.
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in analyzed solutions was determined using the bulk magnetic
susceptibility shift (BMS).[29]
Synthetic procedures
3-[3-[(Bis-pyridin-2-ylmethyl-amino)-methyl]-4-hydroxy-5-(4,7,10-
tris-tert-butoxycarbonylmethyl-1,4,7,10tetraaza-cyclododec-1-
ylmethyl)-phenyl]-2-tert-butoxycarbonylamino-propionic acid
methyl ester (2): DO3A-tBu (1.544 g, 3.00 mmol) and paraformalde-
hyde (0.198 g, 6.6 mmol) in 10 mL toluene were stirred at 60 °C until
the solution became clear. Then, compound 1 (3.040 g, 6.00 mmol)
was added to the reaction mixture and a few drops of DBU were
added shortly afterwards, followed by stirring for 6 h at 110 °C.
Upon reaction completion, the reaction mixture was evaporated
and purified by silica gel column chromatography using DCM/
MeOH (v/v, 20 :1) as the eluent, affording 1.333 g (43%) of
compound 2 as a light yellow oil. 1H NMR (CDCl3, 300MHz): δ
(ppm): 1.40, 1.42 (s, 36H, CCH3); 2.22–3.49 (br, 24H, NCH2); 3.69 (s,
3H, OCH3); 3.81 (s, 6H, NCH2C); 4.39–4.58 (m, 1H, NHCH); 6.83–6.96
(m, 2H, phOH); 7.09–8.72 (m, 8H, pyridyl). 13C NMR (CDCl3, 75MHz):
δ (ppm): 27.8, 28.1 (12C, CCH3); 37.3 (1C, phCH2CH); 51.4, 51.6, 51.7,
51.9, 52.6, 52.7 (8C, NCH2CH2); 53.5 (1C, OCH3); 55.6, 56.1 (3C,
NCH2CO); 54.7 (2C, phCH2N); 57.3 (1C, NH2CH); 60.1 (2C, pyCH2);
80.5, 82.2 (4C, CCH3); 121.7, 122.7 (4C, CCHCH, NCHCH); 123.2, 125.2
(2C, HOCCH); 128.7 (2C, CCHC); 129.9 (1C, CHCCH); 136.3 (2C,
CCHCH); 148.8 (2C, NCHCH); 149.1 (1C, OHC); 155.7 (1C, NHCCO);
160.0 (2C, NCCH); 170.8, 171.1, 172.5 (4C, CO). ESI-TOF/MS: (m/z) [M
+H]+ calcd. for C55H85N8O11
+ : 1033.6332; found: 1033.6325.
2-Amino-3-[3-[(bis-pyridin-2-ylmethyl-amino)-methyl]-4-hydroxy-
5-(4,7,10-tris-carboxymethyl-1,4,7,10 tetraaza-cyclododec-1-
ylmethyl)-phenyl]-propionic acid methyl ester (L1): Compound 2
(1.033 g, 1.00 mmol) was dissolved in 5 mL TFA/DCM (v/v 50/50)
and the solution was stirred at room temperature overnight. After
purification by HPLC, pure H3L
1 (0.604 g, 79%) was obtained. 1H
NMR (D2O, 300MHz): δ (ppm): 2.81–3.49 (br, 24H, NCH2); 3.67 (s, 8H,
NCH2Ar); 3.73 (s, 3H, OCH3); 4.26–4.42 (m, 1H, NH2CH); 6.77, 7.31 (s,
2H, ph); 7.19 (d, J=7.2 Hz, 2H, NCHCH); 7.21 (d, J=7.0 Hz, 2H,
NCCH); 7.63 (t, J=7.7 Hz, 2H, CHCHCH); 8.32 (d, J=4.5 Hz, 2H,
NCHCH). 13C NMR (D2O, 75MHz): δ (ppm): 34.6 (1C, phCH2CH); 48.5–
50.7 (8C, NCH2CH2); 53.4 (1C, OCH3); 53.6 (1C, NH2CH); 55.6, 56.3,
56.8 (3C, NCH2CO); 55.9 (2C„ phCH2N); 59.3 (2C, pyCH2); 123.3, 123.6
(4C, CCHCH); 124.4, 126.4 (2C, HOCCH); 130.8 (1C, CHCCH); 132.4
(2C, CCHC); 138.2 (2C, CCHCH); 148.2 (2C, NCCH); 154.0 (1C, OHC);
156.0 (2C, NCHCH); 170.7 (4C, CO). ESI-TOF/MS: (m/z) [M  H]  calcd.
for C38H51N8O9
  : 763.3785; found: 763.3785.
2-Amino-3-[3-[(bis-pyridin-2-ylmethyl-amino)-methyl]-4-hydroxy-
5-(4,7,10-tris-carboxymethyl-1,4,7,10 tetraaza-cyclododec-1-
ylmethyl)-phenyl]-propionic acid (L2): Compound L1 (0.306 g,
0.40 mmol) was dissolved in 5 mL methanol and LiOH was added.
Then the mixture was stirred at room temperature overnight. After
filtering, the methanol was evaporated. The crude mixture was
dissolved in water and the pH was adjusted to 7. The mixture was
then purified by HPLC to yield 0.222 g (74%) of H3L
2 as a light
yellow powder. 1H NMR (D2O, 300MHz): δ (ppm): 2.61–3.49 (br, 24H,
NCH2); 3.53–3.87 (br, 8H, NCH2Ar); 3.95–4.05 (m, 1H, NH2CH); 6.83,
6.96 (s, 2H, phOH); 7.02–7.39 (m, 4H, NCHCH, NCCH); 7.64 (t, J=
7.3 Hz, 2H, CHCHCH); 8.24 (d, J=4.3 Hz, 2H, NCHCH). 13C NMR (D2O,
75MHz): δ (ppm): 34.8 (1C, phCH2CH); 47.7, 50.7 (8C, NCH2CH2); 52.6
(1C, NH2CH); 53.4, 54.5 (3C, NCH2CO); 56.7 (2C, phCH2N); 58.7 (2C,
pyCH2); 126.4, 127.5 (4C, CCHCH); 127.9 (2C, HOCCH); 134.3 (2C,
CCHC); 134.8 (1C, CHCCH); 141.5 (2C, CCHCH); 146.5 (2C, NCCH);
151.9 (2C, NCHCH); 152.7 (1C, OHC); 163.0, 162.6 (2C, NCCH); 173.3
(4C, CO). ESI-TOF/MS: (m/z) [M  H]  calcd. for C37H49N8O9
  : 749.3628;
found: 749.3631.
2-tert-Butoxycarbonylamino-3-[4-hydroxy-3-(4,7,10-tris-tert-
butoxycarbonylmethyl-1,4,7,10tetraazacyclododec-1-ylmethyl)-
phenyl]-propionic acid methyl ester (3): DO3A-tBu (1.029 g,
2.00 mmol) and paraformaldehyde (0.132 g, 4.40 mmol) were stirred
in 5 mL toluene at 65 °C until the solution became clear. Then, Boc-
Tyrosine-OMe (1.299 g, 4.40 mmol) was added to the reaction
mixture and a few drops of DBU were added shortly afterwards,
followed by stirring for 3 h at 65 °C. Upon reaction completion, the
reaction mixture was evaporated and purified by silica gel column
chromatography using DCM/MeOH (v/v, 20 :1) as the eluent to yield
1.217 g (74%) of 3 as light yellow oil. 1H NMR (CDCl3, 300MHz): δ
(ppm): 1.01–1.17 (br, 36H, CCH3), 1.79–2.78 (br, 26H, NCH2), 3.35 (s,
3H, OCH3), 4.65 (m, 1H, NHCH), 6.47 (d, J=7.9 Hz, 1H, HOC=CH),
6.61 (s, 1H, C=CH=C); 6.85–7.00 (m, 1H, C=CH=CH). 13C NMR (CDCl3,
75MHz): δ (ppm): 27.8, 28.1 (12C, CH2CH3); 36.9 (1C, phCH2); 46.3
(1C, OCH3); 49.5, 49.6 (8C, NCH2CH2); 51.9 (1C, phCH2N); 53.7, 55.2,
55.8 (3C, NCH2CO); 54.6 (1C, NHCH2); 79.5, 82.0, 82.1, (4C, C(CH3)3);
117.9, 123.7, 126.7, 129.3, 132.7 (5C, ph); 154.3 (1C, OHC); 154.7 (1C,
NHCO); 171.9 (3C, CH2CO); 172.4 (1C, CHCO). ESI-TOF/MS: (m/z) [M+
H]+ calcd. for C42H72N5O11
+ : 822.5223, found: 822.5225.
2-Amino-3-[4-hydroxy-3-(4,7,10-tris-carboxymethyl-1,4,7,10tet-
raaza-cyclododec-1-ylmethyl)-phenyl]-propionic acid methyl es-
ter (L3): Compound 3 (1.200 g, 1.46 mmol) was dissolved in 6 mL
TFA/DCM (v/v 50/50) and the solution was stirred at room temper-
ature overnight. Pure H3L3 (0.671 g, 83%) was obtained by HPLC. 1H
NMR (D2O, 300MHz): δ (ppm): 2.99–3.49 (br, 24H, NCH2, phCH2CH),
3.58 (s, 3H, OCH3), 3.94 (s, 2H, phCH2N), 3.98–4.13 (m, 1H, NH2CH),
6.78–6.93 (br, 1H, C=CH=CH), 7.12 (d, 1H, J=6.6 Hz, HOC=CH), 7.21
(s, 1H, C=CH=CH). 13C NMR (D2O, 75MHz): δ (ppm): 34.7 (1C, phCH2);
46.7 (1C, OCH3); 47.8 (1C, NH2CH); 51.6 (1C, phCH2N); 52.1, 53.5, 54.1,
54.5 (8C, NCH2CH2); 55.5 (3C, NCH2CO); 116.13, 126.1, 133.2, 133.5
(5C, ph); 154.7 (1C, OHC); 169.3, 169.9 (3C, CH2CO); 173.6 (1C,
CHCO). ESI-TOF/MS: (m/z) [M  H]  calcd. for C25H38N5O9
  m/z
552.2675; found: 552.2677.
2-Amino-3-[4-hydroxy-3-(4,7,10-tris-carboxymethyl-1,4,7,10tet-
raaza-cyclododec-1-ylmethyl)-phenyl]-propionic acid (L4): Com-
pound L3 (0.277 g, 0.50 mmol) was dissolved in 5 mL methanol and
LiOH was added. Then the mixture was stirred at room temperature
overnight. After filtering, methanol was evaporated. The crude
mixture was dissolved in water and the pH was adjusted to 7. Then
the mixture was purified by HPLC to yield 0.129 g (71%) of H3L
4 as
a white powder. 1H NMR (D2O, 300MHz): δ (ppm): 2.80–3.39 (br,
24H, NCH2, phCH2CH), 3.72 (s, 2H, phCH2N), 4.22–4.42 (m, 1H,
NH2CH), 6.65–6.85 (br, 2H, C=CH=CH), 6.95–7.11 (br, 1H, HOC=CH),
7.13–7.30 (m, 1H, C=CH=CH). 13C NMR (D2O, 75MHz): δ (ppm): 34.6,
35.2, 35.7 (1C, phCH2CH); 53.5, 53.8 (1C, phCH2N); 55.0, 55.2 (8C,
NCH2CH2); 55.5, 55.7 (3C, NCH2CO); 56.5, 56.6 (1C, NH2CH); 116.7,
126.1, 127.1, 128.1, 131.5, 131.9, 133.2 (5C, ph); 153.9, 154.1 (1C,
OHC); 170.4, 172.8, 173.8 (4C, CO). ESI-TOF/MS: (m/z) [M  H]  calcd.
for C24H36N5O9
  : 538.2519; found: 538.2519.
General procedure for the preparation of the Eu3+ and Gd3+
complexes: The introduction of the europium (for L1  4) or
gadolinium (for L1  2) ions into the macrocyclic framework was
carried out at pH ~7.0 adjusted by 0.1 M NaOH solution. To a
stirred aqueous solution of ligand, a solution of EuCl3 · 6H2O or
GdCl3 · 6H2O was prepared in water and was added dropwise to the
ligand solution in 1 :1 molar ratios. The reaction mixture was heated
to 50 °C and stirred overnight. The pH of the solution was
periodically adjusted to 7.0 by addition of 0.1 M NaOH solution. The
reaction mixture was then cooled to room temperature. The yellow
solid compound was obtained by lyophilization. The formation of
the metal complexes EuL1  4 was confirmed by mass spectrometry.
EuL1: ESI-LRMS: (m/z) [M+H]+ calcd. for C38H50EuN8O9+ : 915.3;
found: 915.3.
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GdL1: ESI-LRMS: (m/z) [M  H]  calcd. for C38H48GdN8O9
  : 918.3;
found: 918.3.
EuL2: ESI-LRMS: (m/z) [M  H]  calcd. for C37H46EuN8O9  : 899.3; found:
899.3.
GdL2: ESI-LRMS: (m/z) [M  H]  calcd. for C37H46GdN8O9
  : 904.3;
found: 904.3.
EuL3: ESI-LRMS: (m/z) [M+H]+ calcd. for C25H37EuN5O9+ : 704.2;
found: 704.2.
EuL4: ESI-LRMS: (m/z) [M  H]  calcd. for C24H33EuN5O9
  : 688.1; found:
688.1.
UV/Vis spectroscopy: UV-Vis spectra of complexes EuL1  4 (50 μM)
in 50 mM HEPES buffer at pH 7.4 were obtained at 25 °C on a Cary
Varian double beam spectrophotometer (Cary). The pH effect on
absorptions of EuL1 (50 μM) was studied with changes of pH values
from 4.57 to 11.26. Zn2+-sensitive absorptions of EuL1,2 were
studied with the addition of various concentrations of Zn2+ (0–
3 mM).
Luminescence studies: The Zn2+-sensitive luminescence spectra of
50 μM complex in 50 mM HEPES buffer at pH 7.4 were measured at
25 °C (excitation at 322 nm), with the addition of various concen-
trations of Zn2+ (0–4.0 equiv. of Zn2+). The pH effect on
luminescence of EuL1,2 and EuL1,2Zn was studied with changes of
pH values from 4 to 12, respectively. The pKa values were fitted by a
Boltzmann-type sigmoid.[30] Association constants were determined
by analysing the emission spectra in the range 560–720 nm with
the HYPERQUAD 2008 (HypSpec) program.[31]
Zn2+-binding titrations: All the Zn2+-binding titrations were
measured in 50 mM HEPES buffer at pH 7.4 at 25 °C. The total molar
concentration of complex and Zn2+ was 50 μM.
Metal ion selectivity: For metal ion selectivity experiments, stock
solutions (0.05 M) of NaCl, KCl, CaCl2, MgCl2, FeCl2, FeCl3, CuCl2 and
ZnCl2 were prepared. The appropriate concentrations (50 μM) of
Eu3+ complex were prepared by the dilution method using HPLC
grade water and HEPES buffer. All data were recorded in HEPES
buffer (50 mM, pH 7.4); excitation wavelength at 322 nm; slit widths
were 1 nm for both excitation and emission.
Relaxometric Titrations: Proton longitudinal relaxometric titrations
with Zn2+ were performed at 7.0 T, 25 °C, and pH 7.4 (50 mM HEPES
buffer) using inversion recovery (T1) pulse sequences. A ZnCl2
solution of known concentration was added stepwise to the GdL1  2
solution (starting concentration 3.0 mM Gd3+), and measurements
of T1 were performed after each addition of the analyte. The
longitudinal relaxivities, r1, were calculated from Eq. 1 where T1,obs is
the measured T1, T1d is the diamagnetic contribution of the solvent,
and [Gd] is the actual Gd3+ concentration at each point of the
titration.
1=T1,obs ¼ T1d þ r1 � ½Gd� (1)
DFT calculations: Geometry optimizations and analytical frequency
calculations of the EuL1 and EuL1ZnCl2 systems were carried out
using the Gaussian 09 program package.[32] The frequency analysis
confirmed that the optimized geometries corresponded to local
energy minima in all cases. In these calculations we used the hybrid
meta generalized gradient approximation (hybrid meta-GGA) with
the TPSSh exchange-correlation functional.[33] Relativistic effects
were considered using the large-core effective core potential of
Dolg et al.[34] for Eu, in combination with the associated (7s6p5d)/
[5s4p3d] GTO valence basis. The 6-31G(d,p) basis set was used for
all other atoms. The TPSSh functional in combination with the
large-core approximation was found to provide good results in
studies focusing on the structures and energetics of lanthanide
complexes.[35] The quality of the integration grid was increased
from the default values using the integral=ultrafine keyword in
Gaussian 09.
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